Tech Company Financing Transactions

Kadmus Pharmaceuticals Funding Round

Vengrowth Asset Management, Edbi and Sanderling Ventures invested in a $15.3 million Series A funding round for Kadmus Pharmaceuticals. The financing round was announced by the company on 2/10/2004.

Transaction Overview

Company Name
Kadmus Pharmaceuticals
Announced On
2/10/2004
Transaction Type
Venture Equity
Amount
$15,300,000
Round
Series A
Investors

Vengrowth Asset Management (Lead Investor) (Jeffrey Courtney)

Edbi

Sanderling Ventures

SB Life Science Ventures

Proceeds Purpose
Proceeds of this financing will be used to expand Kadmus' Canadian operations and advance the development of Kadmus' product portfolio, including completion of a Phase II clinical study of the company's lead drug candidate, KDS-2000, a topical formulation targeting neuropathic pain.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
101 Theory 100
Irvine, CA 92617
USA
Phone
(949) 725-3700
Website
www.kadmuspharma.com
Email Address
[email protected]
Overview
Kadmus is a privately-held biopharmaceutical company that commercially exploits endocannabinoid pathways to develop innovative therapeutics. Endocannabinoids are naturally occurring signaling molecules whose functions include regulating pain and body weight.
Profile
Kadmus Pharmaceuticals LinkedIn Company Profile
Social Media
Kadmus Pharmaceuticals Company Twitter Account
Company News
Kadmus Pharmaceuticals News
Facebook
Kadmus Pharmaceuticals on Facebook
YouTube
Kadmus Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Patrick Walsh
  Patrick Walsh LinkedIn Profile  Patrick Walsh Twitter Account  Patrick Walsh News  Patrick Walsh on Facebook
Chief Financial Officer
John Stroh
  John Stroh LinkedIn Profile  John Stroh Twitter Account  John Stroh News  John Stroh on Facebook
Vice President
Edward Monaghan
  Edward Monaghan LinkedIn Profile  Edward Monaghan Twitter Account  Edward Monaghan News  Edward Monaghan on Facebook
Vice President
David Putman
  David Putman LinkedIn Profile  David Putman Twitter Account  David Putman News  David Putman on Facebook
VP - Bus. Development
Jeff Parrott
  Jeff Parrott LinkedIn Profile  Jeff Parrott Twitter Account  Jeff Parrott News  Jeff Parrott on Facebook
VP - R & D
Roger Mailhot
  Roger Mailhot LinkedIn Profile  Roger Mailhot Twitter Account  Roger Mailhot News  Roger Mailhot on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/6/2004: LightPointe venture capital transaction
Next: 2/10/2004: 3PAR venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.